Invasive Group A streptococcal infections: are we facing a new outbreak? A case series with the experience of a single tertiary center.
Case series
Children
Epidemiology
Streptococcus pyogenes
iGAS infection
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
19 Jul 2023
19 Jul 2023
Historique:
received:
13
06
2023
accepted:
10
07
2023
medline:
21
7
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
In pediatric age, Group A Streptococcus (GAS) is responsible for a wide spectrum of clinical manifestations, from mild localized infections to life-threatening invasive diseases. In December 2022, the World Health Organization reported an increased incidence of scarlet fever and invasive GAS infections (iGAS) cases in Europe and the United States. In line with these observations, surveillance has been strengthened in our Region, allowing the identification of certified or highly suspected forms of iGAS. We report here 4 emblematic cases of iGAS admitted to our Intensive Care Unit (ICU) in the short time span from mid-February to mid-March 2023. Particularly, we describe a case of pleuropneumonia (4 year old boy) and a case of respiratory failure (2 year old boy), who necessitated Non-Invasive Ventilation support, a case of Streptococcal Toxic Shock Syndrome (6 year old girl), presenting with multi-organ failure, who needed Invasive Ventilation, and a case of meningitis (5 year old girl). All these patients needed intensive care support. Accurate differential diagnosis and early treatment both could help to reduce the transmission of GAS and consequently the risk of severe iGAS. These cases confirmed the need for close monitoring and appropriate notification, in order to verify their actual increased incidence.
Sections du résumé
BACKGROUND
BACKGROUND
In pediatric age, Group A Streptococcus (GAS) is responsible for a wide spectrum of clinical manifestations, from mild localized infections to life-threatening invasive diseases. In December 2022, the World Health Organization reported an increased incidence of scarlet fever and invasive GAS infections (iGAS) cases in Europe and the United States. In line with these observations, surveillance has been strengthened in our Region, allowing the identification of certified or highly suspected forms of iGAS.
CASE PRESENTATION
METHODS
We report here 4 emblematic cases of iGAS admitted to our Intensive Care Unit (ICU) in the short time span from mid-February to mid-March 2023. Particularly, we describe a case of pleuropneumonia (4 year old boy) and a case of respiratory failure (2 year old boy), who necessitated Non-Invasive Ventilation support, a case of Streptococcal Toxic Shock Syndrome (6 year old girl), presenting with multi-organ failure, who needed Invasive Ventilation, and a case of meningitis (5 year old girl). All these patients needed intensive care support.
CONCLUSIONS
CONCLUSIONS
Accurate differential diagnosis and early treatment both could help to reduce the transmission of GAS and consequently the risk of severe iGAS. These cases confirmed the need for close monitoring and appropriate notification, in order to verify their actual increased incidence.
Identifiants
pubmed: 37468965
doi: 10.1186/s13052-023-01494-9
pii: 10.1186/s13052-023-01494-9
pmc: PMC10354902
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88Informations de copyright
© 2023. The Author(s).
Références
Euro Surveill. 2023 Jan;28(1):
pubmed: 36695450
Cochrane Database Syst Rev. 2016 Jul 04;7:CD010502
pubmed: 27374000
BMC Infect Dis. 2020 Jul 13;20(1):507
pubmed: 32660436
Front Cell Infect Microbiol. 2020 Oct 15;10:563627
pubmed: 33178623
Infect Drug Resist. 2020 Dec 31;13:4739-4749
pubmed: 33408489
New Microbiol. 2023 Feb;46(1):37-42
pubmed: 36853816
Clin Microbiol Rev. 2000 Jul;13(3):470-511
pubmed: 10885988
Drugs. 2012 Jun 18;72(9):1213-27
pubmed: 22686614
Euro Surveill. 2023 Jan;28(1):
pubmed: 36695447